Aurobindo Pharma
Aurobindo pharma initiate recall of blood pressure drug Ibesartan
November 6, 2018Manufacturing and Production, Research and Development Aurobindo Pharma, FDA, heart drug, ibesartan, recall
Indian pharma firm Aurobindo Pharma Ltd has initiated a voluntary recall of 22 batches of blood pressure drug Ibesartan, due …
Pharma manufacturing news in brief
May 31, 2011Manufacturing and Production Aurobindo Pharma, Gallus, Lonza, ProMetic, Unigene
This week’s round-up of pharmaceutical manufacturing news includes new contracts for ProMetic and Unigene, plus facility updates from Aurobindo, Gallus …
Aurobindo sells Chinese API unit to Sinopharm
January 13, 2011Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient
Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
September 14, 2026
